Pharma BD Deal Intelligence
Sanofi-Aventis Group / ImmunoGen, Inc.
2005 · Co-Development · $18M · Complete
Announcement Sentiment
70
Positive
Sanofi-Aventis extends antibody-drug conjugate (ADC/TAP) research collaboration with ImmunoGen; extension begins Sept 2006 with additional committed funding. Strategically notable ADC platform deal.
Key facts
- Announced Aug 31, 2005
- Closed Aug 31, 2005
- Deal value $18M
- Deal type Co-Development
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals